Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Late-Stage Pipeline

80%

8 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
8(80.0%)
Phase 2
2(20.0%)
10Total
Phase 4(8)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT05305872Phase 4Recruiting

Gandouling in the Treatment of Wilson's Disease

Role: lead

NCT04695990Phase 2Unknown

Study on the Clinical and Mechanism of Wenyang Huoxue Decoction in Treating Heart Failure After Myocardial Infarction

Role: lead

NCT04667598Phase 2Unknown

Clinical and Metabonomics Study on the Treatment of Heart Failure After Myocardial Infarction With Modified Wenxin Decoction

Role: lead

NCT02857959Phase 4Unknown

One Dose Versus Three Weekly Doses of Benzathine Penicillin G for Patients With Early Syphilis

Role: lead

NCT03179527Phase 4Unknown

Research on the Clinical Effect of Shuanghe Decoction in Treating Unstable Angina.

Role: lead

NCT03179618Phase 4Unknown

Research on the Clinical Effect of Xuefu Zhuyu Decoction in Treating Unstable Angina.

Role: lead

NCT03179514Phase 4Unknown

Effect of Gualou Xiebai Banxia Decoction With Danshen Decoction in Treating Unstable Angina.

Role: lead

NCT03171597Phase 4Unknown

Research on the Clinical Effect of Effective Prescription in Treating Unstable Angina.

Role: lead

NCT03072121Phase 4Unknown

Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization

Role: lead

NCT03072082Phase 4Unknown

Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to Revascularization

Role: lead

All 10 trials loaded